Zurich Cantonal Bank’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,275
Closed -$13.1K 2682
2024
Q4
$13.1K Sell
1,275
-296
-19% -$3.69K ﹤0.01% 2603
2024
Q3
$21.3K Hold
1,571
﹤0.01% 2595
2024
Q2
$20.4K Sell
1,571
-32
-2% -$396 ﹤0.01% 2589
2024
Q1
$15.1K Buy
+1,603
New +$15.6K ﹤0.01% 2643

Other funds holding THRD

Zurich Cantonal Bank's THRD Position: Q1 2025 in Review

Zurich Cantonal Bank sold out of Third Harmonic Bio (THRD) in Q1 2025, closing a stake of 1,275 shares — an estimated $13.1K sold.

Zurich Cantonal Bank first reported a position in THRD in Q1 2024 and held it in 4 quarters. The position peaked at $21.3K in Q3 2024. 99 funds tracked by Wall St. Rank hold THRD as of Q1 2025.

  • Zurich Cantonal Bank reported no remaining Third Harmonic Bio position as of Q1 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 1,275 Third Harmonic Bio shares in Q1 2025, an estimated $13.1K.
  • Zurich Cantonal Bank first reported a position in Third Harmonic Bio in Q1 2024 and held it in 4 quarters.
  • Zurich Cantonal Bank's Third Harmonic Bio position peaked at $21.3K in Q3 2024.
  • 99 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q1 2025.

Based on Zurich Cantonal Bank's 13F filing for Q1 2025, filed 7 May 2025.